Rosen Law Firm Urges Caribou Biosciences, Inc. (NASDAQ: CRBU) Investors to Contact the Firm for Information About Their Rights
Published on December 27, 2024
having insufficient cash, liquidity, and/or other capital to fund its current business operations, including preclinical research activities